Visiopharm’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Visiopharm is a software firm that develops and distributes image analysis and stereology software for the biopharmaceutical industry. Read more

Visiopharm is a software firm that develops and distributes image analysis and stereology software for the biopharmaceutical industry. Read more

Michael Grunkin's photo - CEO of Visiopharm

CEO

Michael Grunkin

CEO Approval Rating

68/100

Founded:

2001

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

LigoLab is perceived as one of Visiopharm's biggest rivals. LigoLab was founded in 2006 in Glendale, California. LigoLab is in the Internet Software field. LigoLab generates $4.4M less revenue than Visiopharm.

Indica Labs is Visiopharm's #2 rival. Indica Labs is a Private company that was founded in 2011 in Albuquerque, New Mexico. Indica Labs competes in the Internet Software field. Compared to Visiopharm, Indica Labs has 18 fewer employees.

Mikroscan is one of Visiopharm's top competitors. Mikroscan's headquarters is in Carlsbad, California, and was founded in 2009. Like Visiopharm, Mikroscan also operates in the Internet Software industry. Mikroscan generates 37% of Visiopharm's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 78 a good estimate for Visiopharm's Employee count?

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

-

Dec 2012

Source »
undisclosed
-

These are all the companies that Visiopharm has acquired. Visiopharm's latest acquisition was in Dec 2012.

Visiopharm Funding History

$0$14.7M

Since Visiopharm was founded in 2001, it has participated in 3 rounds of funding. In total Visiopharm has raised $14.7M. Visiopharm's last funding round was on Aug 2020 for a total of $0

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Venture Round
Aug 2020
--

BankInvest

Venture Round
Aug 2018
$14.7M
Private Equity Round
Oct 2007
--

Total Funding: $14.7M

Since Visiopharm was founded in 2001, it has participated in 3 rounds of funding. In total Visiopharm has raised $14.7M. Visiopharm's last funding round was on Aug 2020 for a total of $0

Investments

No recent investments found related to Visiopharm

Visiopharm News

February 5, 2020FinanzNachrichten

Visiopharm announces long-term exclusive contract with Marylou Tyler

COPENHAGEN, Denmark, Feb. 5, 2020 /PRNewswire/ -- Visiopharm, the leader in AI-driven digital precisi... See more »
September 10, 2018StreetInsider

Fluidigm (FLDM) Reports Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis

Fluidigm Corporation (NASDAQ: FLDM) and Visiopharm A/S today announced a co-marketing relationship to... See more »
May 3, 2017BioPortfolio

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology

Visiopharm AS announces the first result of their multifaceted strategy to apply Deep Learning techno... See more »
November 30, 2016BioPortfolio

Visiopharm AS acquires LRI Imaging AB to become a leader in Diagnostic Digital Pathology

Visiopharm AS today announces its acquisition of LRI Imaging AB.H&248;rsholm Denmark PRWEB December 0... See more »
March 4, 2015BIOPORTFOLIO

Visiopharm Appoints Patrik Dahlen as Chairman of the Board

Patrik Dahl&233;n previously the CEO of Dako has been announced as Chairman of the Board at Visiophar... See more »

Visiopharm Blogs

August 20, 2020Visiopharm Blog

Visiopharm granted patents for stain quality management in tissue biomarkers

Visiopharm®, the Denmark-based leader in artificial intelligence-driven image analysis, tissue mining... See more »
August 4, 2020Visiopharm Blog

Partnership accelerates discovery with image analysis and management integration

Despite the ever-expanding array of technological advancements, image-based research remains limited ... See more »
June 26, 2020Visiopharm Blog

Deep learning improves the accuracy of multispectral image analysis for digital pathology

Dr. Heather Stevenson explains how her research on hepatic macrophage phenotypes in chronic liver dis... See more »
May 3, 2020Visiopharm Blog

Visiopharm announces Ralf Huss as chairperson of the scientific advisory board

Visiopharm is very happy to announce that Ralf Huss, M.D, Ph.D. has been appointed as the chairperson... See more »
April 1, 2020Visiopharm Blog

Visiopharm Welcomes Dirk Vossen as Chief Diagnostics Office

Visiopharm is pleased to announce that Dirk Vossen Ph.D. has joined the company as its new Chief Diag... See more »
June 21, 2016Visiopharm Blog

A New Chief Scientific Officer and Chief Marketing Officer Join the Visiopharm Executive Team

Andreas Schønau joins Visiopharm as Chief Scientific Officer. He received his M.Sc. in Enginee... See more »
June 21, 2016Visiopharm Blog

Sakura's VisionTek Systems Added to List of Compatible Slide Scanners

We recently had the opportunity to test some Sakura images at the Pathology Informatics meeting last ... See more »

Visiopharm Press Releases

September 5, 2017PRWeb

Neagen and Visiopharm announce new Technical Integration between image analysis and PACS to meet demands from pathologists

Neagen and Visiopharm today announce an integration, which improves the data quality of cancer patien... See more »
November 20, 2016PRWeb

Pathcore Partners with Visiopharm to Provide a Powerful Image Analysis and Management Solution for Digital Pathology

The partnership between Pathcore and Visiopharm will provide a powerful image analysis and management... See more »
March 15, 2016PRWeb

Visiopharm Powers Up With VIS 6.0

Today Visiopharm, the leading provider of quantitative digital pathology software for diagnostics and... See more »
May 4, 2015PRWEB

Visiopharm Closes Investment Round to Grow Diagnostic Digital Pathology Business

Visiopharm announces today the closing of a private round of financing with NorthCap Partners. The in... See more »
March 9, 2015PRWEB

Herlev University Hospital Selects Oncotopix® Dx for Routine Cancer Diagnostics

Herlev University Hospital selects ONCOtopix Dx a truly open quantitative digital pathology solution.... See more »
March 4, 2015PRWEB

Visiopharm Appoints Patrik Dahlen as Chairman of the Board

Patrik Dahlén, previously the CEO of Dako, has been announced as Chairman of the Board at Visiopharm ... See more »
September 29, 2014PRWEB

Visiopharm Expands Into the Benelux Region with New Office and Leadership

Visiopharm expands into Benelux with a new office and under the leadership of Mr. Jan Pijenburg as Sa... See more »

Visiopharm Videos

Social Statistics

Headquarters

Agern Alle 24

Hoersholm, North Jutland2970

45-88-20-2088

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Visiopharm is a software firm that develops and distributes image analysis and stereology software for the biopharmaceutical industry. Visiopharm was founded in 2001. Visiopharm's headquarters is located in Hoersholm, North Jutland, DK 2970. It has ra...

CEO

Visiopharm's CEO, Michael Grunkin, currently has an approval rating of 68%. Visiopharm's primary competitors are LigoLab, Indica Labs & Mikroscan.

Website

visiopharm.com

Frequently Asked Questions about Visiopharm

  1. When was Visiopharm founded?

    Visiopharm was founded in 2001
  2. Who is Visiopharm's CEO?

    Visiopharm's CEO is Michael Grunkin
  3. How much revenue does Visiopharm generate?

    Visiopharm generates $12.4M in revenue
  4. How much funding does Visiopharm have?

    Visiopharm has historically raised $14.7M in funding
  1. Where is Visiopharm's headquarters?

    Visiopharm's headquarters is in Hoersholm North Jutland, DK
  2. How many employees does Visiopharm have?

    Visiopharm has 78 employees
  3. What sector does Visiopharm operate in?

    Visiopharm is in Internet Software
  4. Who are Visiopharm's competitors?

    Visiopharm's top competitors are LigoLab, Indica Labs, Mikroscan